Chinese artificial intelligence driven drug discovery firm XtalPi Holdings has projected its first full year profit following a sharp rise in revenue, signaling growing commercial traction for AI powered pharmaceutical research in China. The Shenzhen based company said it expects to report a
A milestone moment for AI driven drug development China’s biotech sector has reached a landmark moment as Hangzhou based start-up MindRank advanced its weight loss drug into Phase 3 clinical trials. The development marks the first time a Category 1 new drug in
A Bold Vision for the Future of Medicine Biotechnology company Insilico Medicine is pursuing an ambitious goal that blends artificial intelligence with the uncertainties of drug discovery. Backed by the Hong Kong Investment Corporation, the firm is working to build what its founder
A new report from a US congressional commission has issued an urgent alert about China’s accelerating rise in the biotechnology field, calling the speed and scale of its progress “sobering, even frightening”. The National Security Commission on Emerging Biotechnology (NSCEB), which spent two
